Broadcom Forecast, price target & analysts
Broadcom Target price 2025 - Analyst rating & recommendation
Broadcom Classifications & Recommendation:
Broadcom Price Target
| Target Price | $243.97 |
| Price | $181.94 |
| Potential | 34.09% |
| Number of Estimates | 34 |
| 34 Analysts have issued a price target Broadcom 2026 . The average Broadcom target price is $243.97. This is 34.09% higher than the current stock price. The highest price target is $300.00 64.89% , the lowest is $198.00 8.83% . | |
| A rating was issued by 44 analysts: 39 Analysts recommend Broadcom to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Broadcom stock has an average upside potential 2026 of 34.09% . Most analysts recommend the Broadcom stock at Purchase. |
Sales and Margin forecast 2025, 2026 & 2027
35 Analysts have issued a sales forecast Broadcom 2025 . The average Broadcom sales estimate is $62.6b . This is 14.83% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $65.8b 20.73% , the lowest is $61.3b 12.34% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $51.6b | 43.99% |
|---|---|---|
| 2025 | $62.6b | 21.41% |
| 2026 | $72.5b | 15.78% |
| 2027 | $82.4b | 13.64% |
20 Analysts have issued an Broadcom EBITDA forecast 2025. The average Broadcom EBITDA estimate is $41.8b . This is 44.87% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $45.2b 56.76% , the lowest is $39.9b 38.37% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $25.3b | 24.49% |
|---|---|---|
| 2025 | $41.8b | 65.32% |
| 2026 | $48.2b | 15.43% |
| 2027 | $53.7b | 11.43% |
EBITDA Margin
| 2024 | 48.98% | 13.54% |
|---|---|---|
| 2025 | 66.69% | 36.16% |
| 2026 | 66.49% | 0.30% |
| 2027 | 65.20% | 1.94% |
18 Broadcom Analysts have issued a net profit forecast 2025. The average Broadcom net profit estimate is $21.2b . This is 117.45% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $24.5b 151.69% , the lowest is $17.4b 79.23% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $5.8b | 62.73% |
|---|---|---|
| 2025 | $21.2b | 265.96% |
| 2026 | $27.3b | 29.04% |
| 2027 | $32.2b | 17.84% |
Net Margin
| 2024 | 11.21% | 74.11% |
|---|---|---|
| 2025 | 33.80% | 201.41% |
| 2026 | 37.67% | 11.45% |
| 2027 | 39.07% | 3.72% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
18 Analysts have issued a Broadcom forecast for earnings per share. The average Broadcom EPS is $4.50 . This is 117.39% higher than earnings per share in the financial year 2024. The highest EPS forecast is $5.21 151.69% , the lowest is $3.71 79.23% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $1.23 | 62.73% |
|---|---|---|
| 2025 | $4.50 | 265.85% |
| 2026 | $5.81 | 29.11% |
| 2027 | $6.84 | 17.73% |
P/E ratio
| Current | 87.75 | 76.74% |
|---|---|---|
| 2025 | 40.42 | 53.94% |
| 2026 | 31.32 | 22.51% |
| 2027 | 26.58 | 15.13% |
Based on analysts' sales estimates for 2025, the Broadcom stock is valued at an EV/Sales of 14.58 and an P/S ratio of 13.66 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 16.74 | 4.99% |
|---|---|---|
| 2025 | 14.58 | 12.92% |
| 2026 | 12.59 | 13.63% |
| 2027 | 11.08 | 12.00% |
P/S ratio
| Current | 15.69 | 1.77% |
|---|---|---|
| 2025 | 13.66 | 12.92% |
| 2026 | 11.80 | 13.63% |
| 2027 | 10.38 | 12.00% |
Current Broadcom Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 11 2025 |
| Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Mar 07 2025 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Mar 07 2025 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Mar 07 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Mar 07 2025 |
| Mizuho |
Outperform
➜
Outperform
|
Unchanged | Mar 07 2025 |
| Benchmark |
Buy
➜
Buy
|
Unchanged | Mar 07 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 11 2025 |
|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Mar 07 2025 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Mar 07 2025 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Mar 07 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Mar 07 2025 |
|
Unchanged
Mizuho:
Outperform
➜
Outperform
|
Mar 07 2025 |
|
Unchanged
Benchmark:
Buy
➜
Buy
|
Mar 07 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
